349 related articles for article (PubMed ID: 30399529)
1. Lambda interferons come to light: dual function cytokines mediating antiviral immunity and damage control.
Andreakos E; Zanoni I; Galani IE
Curr Opin Immunol; 2019 Feb; 56():67-75. PubMed ID: 30399529
[TBL] [Abstract][Full Text] [Related]
2. Type III interferons in innate and adaptive immunity in the respiratory tract.
Piperakis A; Galani IE; Andreakos E
Curr Opin Immunol; 2024 Apr; 87():102430. PubMed ID: 38824869
[TBL] [Abstract][Full Text] [Related]
3. Lambda interferons in immunity and autoimmunity.
Vlachiotis S; Andreakos E
J Autoimmun; 2019 Nov; 104():102319. PubMed ID: 31481283
[TBL] [Abstract][Full Text] [Related]
4. Type III IFNs: Beyond antiviral protection.
Kotenko SV; Rivera A; Parker D; Durbin JE
Semin Immunol; 2019 Jun; 43():101303. PubMed ID: 31771761
[TBL] [Abstract][Full Text] [Related]
5. IL-28 and IL-29: newcomers to the interferon family.
Uzé G; Monneron D
Biochimie; 2007; 89(6-7):729-34. PubMed ID: 17367910
[TBL] [Abstract][Full Text] [Related]
6. The unique regulation and functions of type III interferons in antiviral immunity.
Odendall C; Kagan JC
Curr Opin Virol; 2015 Jun; 12():47-52. PubMed ID: 25771505
[TBL] [Abstract][Full Text] [Related]
7. Disruption of Type III Interferon (IFN) Genes
Peterson ST; Kennedy EA; Brigleb PH; Taylor GM; Urbanek K; Bricker TL; Lee S; Shin H; Dermody TS; Boon ACM; Baldridge MT
J Virol; 2019 Nov; 93(22):. PubMed ID: 31462571
[TBL] [Abstract][Full Text] [Related]
8. Interferon-λs: Front-Line Guardians of Immunity and Homeostasis in the Respiratory Tract.
Andreakos E; Salagianni M; Galani IE; Koltsida O
Front Immunol; 2017; 8():1232. PubMed ID: 29033947
[TBL] [Abstract][Full Text] [Related]
9. Interferon-λ Mediates Non-redundant Front-Line Antiviral Protection against Influenza Virus Infection without Compromising Host Fitness.
Galani IE; Triantafyllia V; Eleminiadou EE; Koltsida O; Stavropoulos A; Manioudaki M; Thanos D; Doyle SE; Kotenko SV; Thanopoulou K; Andreakos E
Immunity; 2017 May; 46(5):875-890.e6. PubMed ID: 28514692
[TBL] [Abstract][Full Text] [Related]
10. Beyond Good and Evil: Molecular Mechanisms of Type I and III IFN Functions.
Dowling JW; Forero A
J Immunol; 2022 Jan; 208(2):247-256. PubMed ID: 35017214
[TBL] [Abstract][Full Text] [Related]
11. Interferon lambda in inflammation and autoimmune rheumatic diseases.
Goel RR; Kotenko SV; Kaplan MJ
Nat Rev Rheumatol; 2021 Jun; 17(6):349-362. PubMed ID: 33907323
[TBL] [Abstract][Full Text] [Related]
12. Functions of IFNλs in Anti-Bacterial Immunity at Mucosal Barriers.
Alphonse N; Dickenson RE; Alrehaili A; Odendall C
Front Immunol; 2022; 13():857639. PubMed ID: 35663961
[TBL] [Abstract][Full Text] [Related]
13. Type III IFNs: new layers of complexity in innate antiviral immunity.
Ank N; Paludan SR
Biofactors; 2009; 35(1):82-7. PubMed ID: 19319850
[TBL] [Abstract][Full Text] [Related]
14. Differential induction of interferon stimulated genes between type I and type III interferons is independent of interferon receptor abundance.
Pervolaraki K; Rastgou Talemi S; Albrecht D; Bormann F; Bamford C; Mendoza JL; Garcia KC; McLauchlan J; Höfer T; Stanifer ML; Boulant S
PLoS Pathog; 2018 Nov; 14(11):e1007420. PubMed ID: 30485383
[TBL] [Abstract][Full Text] [Related]
15. Type-Specific Crosstalk Modulates Interferon Signaling in Intestinal Epithelial Cells.
Pervolaraki K; Guo C; Albrecht D; Boulant S; Stanifer ML
J Interferon Cytokine Res; 2019 Oct; 39(10):650-660. PubMed ID: 31199715
[TBL] [Abstract][Full Text] [Related]
16. Structure-function of type I and III interferons.
de Weerd NA; Kurowska AK; Mendoza JL; Schreiber G
Curr Opin Immunol; 2024 Feb; 86():102413. PubMed ID: 38608537
[TBL] [Abstract][Full Text] [Related]
17. Contribution of type III interferons to antiviral immunity: location, location, location.
Kotenko SV; Durbin JE
J Biol Chem; 2017 May; 292(18):7295-7303. PubMed ID: 28289095
[TBL] [Abstract][Full Text] [Related]
18. Novel type III interferons produce anti-tumor effects through multiple functions.
Li Q; Kawamura K; Tada Y; Shimada H; Hiroshima K; Tagawa M
Front Biosci (Landmark Ed); 2013 Jun; 18(3):909-18. PubMed ID: 23747856
[TBL] [Abstract][Full Text] [Related]
19. Type III interferons (IFNs): Emerging Master Regulators of Immunity.
Galani IE; Koltsida O; Andreakos E
Adv Exp Med Biol; 2015; 850():1-15. PubMed ID: 26324342
[TBL] [Abstract][Full Text] [Related]
20. Defining the distinct, intrinsic properties of the novel type I interferon, IFNϵ.
Stifter SA; Matthews AY; Mangan NE; Fung KY; Drew A; Tate MD; Soares da Costa TP; Hampsey D; Mayall J; Hansbro PM; Garcia Minambres A; Eid SG; Mak J; Scoble J; Lovrecz G; deWeerd NA; Hertzog PJ
J Biol Chem; 2018 Mar; 293(9):3168-3179. PubMed ID: 29187603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
